- Home
- STRO vs FORA Comparison
STRO vs FORA Comparison
Compare STRO & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- FORA
- Stock Information
- Founded
- STRO 2003
- FORA 2014
- Country
- STRO United States
- FORA United States
- Employees
- STRO N/A
- FORA N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- FORA Computer Software: Prepackaged Software
- Sector
- STRO Health Care
- FORA Technology
- Exchange
- STRO Nasdaq
- FORA Nasdaq
- Market Cap
- STRO 74.3M
- FORA 60.2M
- IPO Year
- STRO 2018
- FORA N/A
- Fundamental
- Price
- STRO $0.89
- FORA $2.28
- Analyst Decision
- STRO Hold
- FORA Strong Buy
- Analyst Count
- STRO 7
- FORA 1
- Target Price
- STRO $1.97
- FORA $5.00
- AVG Volume (30 Days)
- STRO 598.8K
- FORA 73.0K
- Earning Date
- STRO 11-12-2025
- FORA 11-12-2025
- Dividend Yield
- STRO N/A
- FORA N/A
- EPS Growth
- STRO N/A
- FORA N/A
- EPS
- STRO N/A
- FORA N/A
- Revenue
- STRO $104,473,000.00
- FORA $25,031,040.00
- Revenue This Year
- STRO $65.42
- FORA $47.82
- Revenue Next Year
- STRO N/A
- FORA $10.11
- P/E Ratio
- STRO N/A
- FORA N/A
- Revenue Growth
- STRO N/A
- FORA 18.59
- 52 Week Low
- STRO $0.52
- FORA $1.64
- 52 Week High
- STRO $4.80
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- STRO 48.52
- FORA 61.78
- Support Level
- STRO $0.85
- FORA $2.20
- Resistance Level
- STRO $1.01
- FORA $2.38
- Average True Range (ATR)
- STRO 0.09
- FORA 0.15
- MACD
- STRO -0.01
- FORA 0.03
- Stochastic Oscillator
- STRO 16.57
- FORA 78.43
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.